Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study

Ren, LL; Li, L; Zhang, L; Li, X; Fu, XR; Wang, XH; Wu, JJ; Sun, ZC; Feng, XY; Chang, Y; Zhou, ZY; Nan, FF; Yan, JQ; Kong, F; Zhang, MZ

Zhang, MZ (通讯作者)，Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022; 38 (1): 42

Abstract

Limited treatment options are available for relapsed or refractory diffuse large B cell lymphoma (RR DLBCL). Few clinical studies have reported the us......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索